Literature DB >> 30230404

Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

Kirsten E Schoonover1, Stacy L Queern2,3, Suzanne E Lapi2,3, Rosalinda C Roberts4.   

Abstract

Objectives: Several schizophrenia brain regions exhibit decreased dysbindin. Dysbindin modulates copper transport crucial for myelination, monoamine metabolism and cellular homeostasis. Schizophrenia patients (SZP) exhibit increased plasma copper, while copper-decreasing agents produce schizophrenia-like behavioural and pathological abnormalities. Therefore, we sought to determine dysbindin and copper transporter protein expression and copper content in SZP.
Methods: We studied the copper-rich substantia nigra (SN) using Western blot and inductively-coupled plasma mass spectrometry. We characterised specific protein domains of copper transporters ATP7A, CTR1, ATP7B and dysbindin isoforms 1 A and 1B/C in SZP (n = 15) and matched controls (n = 11), and SN copper content in SZP (n = 14) and matched controls (n = 11). As a preliminary investigation, we compared medicated (ON; n = 11) versus unmedicated SZP (OFF; n = 4).
Results: SZP exhibited increased C terminus, but not N terminus, ATP7A. SZP expressed less transmembrane CTR1 and dysbindin 1B/C than controls. ON exhibited increased C terminus ATP7A protein versus controls. OFF exhibited less N terminus ATP7A protein than controls and ON, suggesting medication-induced rescue of the ATP7A N terminus. SZP exhibited less SN copper content than controls.Conclusions: These results provide the first evidence of disrupted copper transport in schizophrenia SN that appears to result in a copper-deficient state. Furthermore, copper homeostasis may be modulated by specific dysbindin isoforms and antipsychotic treatment.

Entities:  

Keywords:  Schizophrenia; copper; dysbindin; post-mortem; substantia nigra

Mesh:

Substances:

Year:  2018        PMID: 30230404      PMCID: PMC6424639          DOI: 10.1080/15622975.2018.1523562

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  84 in total

1.  Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

Authors:  K Q Do; A H Trabesinger; M Kirsten-Krüger; C J Lauer; U Dydak; D Hell; F Holsboer; P Boesiger; M Cuénod
Journal:  Eur J Neurosci       Date:  2000-10       Impact factor: 3.386

2.  Impairment of the blood-brain barrier as an aetiological factor in paranoid psychosis.

Authors:  R Axelsson; E Martensson; C Alling
Journal:  Br J Psychiatry       Date:  1982-09       Impact factor: 9.319

3.  Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra.

Authors:  Kirsten E Schoonover; Lesley A McCollum; Rosalinda C Roberts
Journal:  Neuropsychopharmacology       Date:  2016-08-23       Impact factor: 7.853

4.  Dysbindin and Schizophrenia: it's dopamine and glutamate all over again.

Authors:  Francesco Papaleo; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2011-01-01       Impact factor: 13.382

5.  The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis.

Authors:  Dion K Dickman; Graeme W Davis
Journal:  Science       Date:  2009-11-20       Impact factor: 47.728

6.  Localization of copper and copper transporters in the human brain.

Authors:  Katherine M Davies; Dominic J Hare; Veronica Cottam; Nicholas Chen; Leon Hilgers; Glenda Halliday; Julian F B Mercer; Kay L Double
Journal:  Metallomics       Date:  2013-01       Impact factor: 4.526

7.  Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.

Authors:  M M Cox; A M Tucker; J Tang; K Talbot; D C Richer; L Yeh; S E Arnold
Journal:  Genes Brain Behav       Date:  2009-02-11       Impact factor: 3.449

Review 8.  Neuroinflammation and white matter pathology in schizophrenia: systematic review.

Authors:  Souhel Najjar; Daniel M Pearlman
Journal:  Schizophr Res       Date:  2014-06-16       Impact factor: 4.939

9.  Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans.

Authors:  F Papaleo; M C Burdick; J H Callicott; D R Weinberger
Journal:  Mol Psychiatry       Date:  2013-10-22       Impact factor: 15.992

Review 10.  Myelin, copper, and the cuprizone model of schizophrenia.

Authors:  Nicole R Herring; Christine Konradi
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01
View more
  5 in total

1.  Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice.

Authors:  Kirsten E Schoonover; Laura J McMeekin; Charlene B Farmer; Neelu E Varghese; Stacy L Queern; Suzanne E Lapi; Rita M Cowell; Rosalinda C Roberts
Journal:  Brain Res Bull       Date:  2020-08-12       Impact factor: 4.077

Review 2.  Are Essential Trace Elements Effective in Modulation of Mental Disorders? Update and Perspectives.

Authors:  Mehran Shayganfard
Journal:  Biol Trace Elem Res       Date:  2021-04-27       Impact factor: 3.738

3.  Markers of copper transport in the cingulum bundle in schizophrenia.

Authors:  Kirsten E Schoonover; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2021-01-09       Impact factor: 4.939

4.  Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis.

Authors:  Kirsten E Schoonover; Charlene B Farmer; Charity J Morgan; Vidushi Sinha; Laura Odom; Rosalinda C Roberts
Journal:  Schizophr Res       Date:  2021-01-09       Impact factor: 4.939

5.  Correlations Among mRNA Expression Levels of ATP7A, Serum Ceruloplasmin Levels, and Neuronal Metabolism in Unmedicated Major Depressive Disorder.

Authors:  Xuanjun Liu; Shuming Zhong; Lan Yan; Hui Zhao; Ying Wang; Yilei Hu; Yanbin Jia
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-10       Impact factor: 5.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.